Legal & General Group
VIVO

Legal & General Group’s Meridian Bioscience Inc VIVO Stock Holding History

Legal & General Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-108,113
Closed -$3.59M – 3426
2022
Q4 		$3.59M Buy
108,113
+2,479
+2% +$79.8K ﹤0.01% 1594
2022
Q3 		$3.33M Buy
105,634
+839
+0.8% +$27.2K ﹤0.01% 1591
2022
Q2 		$3.19M Buy
104,795
+1,458
+1% +$39.4K ﹤0.01% 1638
2022
Q1 		$2.68M Sell
103,337
-529
-0.5% -$12.6K ﹤0.01% 1852
2021
Q4 		$2.12M Buy
103,866
+3,382
+3% +$64.8K ﹤0.01% 2009
2021
Q3 		$1.93M Buy
100,484
+8,346
+9% +$166K ﹤0.01% 2036
2021
Q2 		$2.04M Sell
92,138
-29,023
-24% -$616K ﹤0.01% 1966
2021
Q1 		$3.18M Buy
121,161
+1,755
+1% +$41.7K ﹤0.01% 1780
2020
Q4 		$2.23M Buy
119,406
+631
+0.5% +$11.8K ﹤0.01% 1844
2020
Q3 		$2.02M Buy
118,775
+189
+0.2% +$3.67K ﹤0.01% 1762
2020
Q2 		$2.76M Buy
118,586
+9,789
+9% +$142K ﹤0.01% 1593
2020
Q1 		$913K Buy
108,797
+1,978
+2% +$16.7K ﹤0.01% 1877
2019
Q4 		$1.04M Buy
106,819
+5,938
+6% +$55.7K ﹤0.01% 2059
2019
Q3 		$957K Sell
100,881
-10,247
-9% -$108K ﹤0.01% 2001
2019
Q2 		$1.32M Buy
111,128
+702
+0.6% +$8.46K ﹤0.01% 1875
2019
Q1 		$1.95M Buy
110,426
+9,402
+9% +$156K ﹤0.01% 1708
2018
Q4 		$1.75M Buy
101,024
+297
+0.3% +$5.07K ﹤0.01% 1647
2018
Q3 		$1.5M Buy
100,727
+6,935
+7% +$108K ﹤0.01% 1818
2018
Q2 		$1.49M Buy
93,792
+4,613
+5% +$68.8K ﹤0.01% 1782
2018
Q1 		$1.27M Buy
89,179
+1,686
+2% +$24.9K ﹤0.01% 1807
2017
Q4 		$1.23M Buy
87,493
+6,614
+8% +$96.8K ﹤0.01% 1818
2017
Q3 		$1.16M Buy
80,879
+333
+0.4% +$4.76K ﹤0.01% 1801
2017
Q2 		$1.27M Buy
80,546
+6,738
+9% +$97.1K ﹤0.01% 1747
2017
Q1 		$1.02M Sell
73,808
-77
-0.1% -$1.08K ﹤0.01% 1787
2016
Q4 		$1.31M Buy
73,885
+35,402
+92% +$622K ﹤0.01% 1638
2016
Q3 		$742K Buy
38,483
+29,250
+317% +$572K ﹤0.01% 1522
2016
Q2 		$178K Buy
9,233
+3,500
+61% +$68.6K ﹤0.01% 1822
2016
Q1 		$120K Sell
5,733
-284
-5% -$5.6K ﹤0.01% 1951
2015
Q4 		$125K Hold
6,017
– – ﹤0.01% 1947
2015
Q3 		$102K Hold
6,017
– – ﹤0.01% 2030
2015
Q2 		$112K Hold
6,017
– – ﹤0.01% 2033
2015
Q1 		$114K Hold
6,017
– – ﹤0.01% 1951
2014
Q4 		$100K Hold
6,017
– – ﹤0.01% 1971
2014
Q3 		$107K Buy
+6,017
New +$118K ﹤0.01% 1845

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Legal & General Group's VIVO Position: Q1 2023 in Review

Legal & General Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 108,113 shares — an estimated $3.59M sold.

Legal & General Group first reported a position in VIVO in Q3 2014 and held it in 34 quarters. The position peaked at $3.59M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Legal & General Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Legal & General Group sold 108,113 Meridian Bioscience Inc shares in Q1 2023, an estimated $3.59M.
  • Legal & General Group first reported a position in Meridian Bioscience Inc in Q3 2014 and held it in 34 quarters.
  • Legal & General Group's Meridian Bioscience Inc position peaked at $3.59M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Legal & General Group's 13F filing for Q1 2023, filed 15 May 2023.